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Context: Maturation delay of germ cells and their progression into
carcinoma in situ (CIS) frequently occurs in intersex patients. A
developmentally delayed germ cell resembles a CIS cell and displays
prolonged expression of immunohistochemical markers used for the
diagnosis of CIS. This questions their applicability in young children.
Objective: The objective of the study was the elaboration of tools to
distinguish germ cells with maturation delay and CIS.
Design:The designwas a qualitative and quantitative analysis of the
expression of diagnostic markers for CIS in gonads of young patients
with undervirilization syndromes.
Setting: The study was conducted in the pathology department of a
university center, specializing in germ cell tumor pathogenesis.
Patients: Fifty-eight formalin-fixed, paraffin-embedded testicular
tissue samples of 30 undervirilized patients (1 month to 23 yr of age)
were analyzed.
Interventions: Interventions included hematoxylin-eosin staining,
immunohistochemistry for octamer binding transcription factor
(OCT)3/4, gene encoding the stem cell factor receptor that has ty-
rosine kinase activity c-KIT, placental/germ alkaline phosphatase
(PLAP), testis-specific protein Y encoded (TSPY), and VASA, double
staining for OCT3/4 and VASA, with ploidy determination by fluo-
rescent in situ hybridization.
Main Outcome Measure: Maturation delay and CIS are charac-
terized by the staining patterns of the immunohistochemical
markers.
Results: CIS was diagnosed in three of 30 patients (10%) and four of
58 gonads (6.9%). Patient age, distribution of OCT3/4-positive cells
throughout the gonad, and their position within the seminiferous
tubule differ between maturation delay and CIS. Abnormal OCT3/4
and testis-specific protein Y encoded expression appear to be of patho-
genetic relevance in the development of these lesions.
Conclusion: The dimorphic expression of OCT3/4 allows distinction
between maturation delay and CIS. Studies in larger patient series
are essential before a biopsy to evaluate the neoplastic risk can even-
tually be proposed as an alternative for gonadectomy. (J Clin En-
docrinol Metab 90: 5295–5303, 2005)
UNDERVIRILIZATION SYNDROMES CAN be causedby errors in testosterone biosynthesis, testicular un-
responsiveness to human chorionic gonadotrophin and LH,
or defects in androgen-dependent target tissues (1). Patients
have an increased risk for the development of germ cell
tumors. In the complete androgen insensitivity syndrome
(CAIS), this risk is estimated at 2–5% (2). In other subgroups,
due to low prevalence, incomplete diagnostic information
and confusing nomenclature, the incidence is actually un-
known. Moreover, criteria for the correct diagnosis of early
neoplasia in young intersex patients are lacking (see text
below). Gonadectomy is the therapy of choice to exclude
tumor development and avoid virilization (1). The optimal
timing for gonadectomy is controversial, especially in CAIS
patients, in whom peripheral conversion of testosterone into
estradiol allows spontaneous development of secondary
sexual characteristics. Patients often underscore the unphys-
iological bioactivity of hormonal replacement therapy, com-
pared with their endogenous hormone production. There-
fore and because the risk of malignancy seems to increase
with increasing age, some authors advise to postpone go-
nadectomy (2–5). However, because germ cell tumors have
been described in (pre)pubertal androgen insensitivity syn-
drome patients, others advocate to remove the gonads or at
least to perform a biopsy at the time of diagnosis (6–8).
The diagnosis of carcinoma in situ (CIS) in children with
intersex conditions is difficult. Morphologically atypical
germ cells are commonly seen in their gonads (8–11) and
seem to correspond with delayed maturation rather than
with malignant transformation (12) (our personal observa-
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tions). Immunohistochemicalmarkers, such as octamer bind-
ing transcription factor involved in regulation of pluripo-
tency (OCT)3/4, placental/germ alkaline phosphatase
(PLAP), and the gene encoding the stem cell factor receptor
that has tyrosine kinase activity (c-KIT), which are normally
expressed in embryonic germ cells are well-established
markers to detect CIS and some invasive germ cell tumors in
adult patients (13–16). These markers are also used to dem-
onstrate CIS in children with intersex conditions (17, 18) and
even in fetal gonads (19). However, many of these markers
showprolonged expression in dysgenetic gonads (20, 21) and
are even normally expressed in young children shortly after
birth (22). Therefore, these markers cannot be used as such
to detect CIS in young patients with gonadal dysgenesis.
Germ cells in gonadal dysgenesis exhibit a developmental
delay and are prone to malignant transformation if they are
able to survive in their inappropriate environment (23). The
aim of our studywas to describe the process frommaturation
delay toward germ cell death or development of CIS in a
series of patientswith undervirilization syndromes and iden-
tify additional tools to distinguish morphological and im-
munohistochemical features of developmental arrest of the
germ cells from a developing CIS. Ploidy determination in
the CIS samples was used to gain further insight into the
chronological steps leading from maturation delay toward
malignancy. The ability to distinguish between these differ-
ent conditions is essential before a biopsy can be proposed
as a safe and temporary alternative for gonadectomy in those
patients in whom preservation of proper hormone produc-
tion is relevant (see above text).
Patients and Methods
Tissue samples
Gonadal tissue samples of 30 patients with undervirilization syn-
dromes, aged 1 month to 23 yr were obtained after biopsy (5.4%) or
gonadectomy (94.6%), performed in the Sophia Children’s Hospital or
collaborating centers. All patients had 46 XY karyotypes. The individual
diagnoses were established on clinical grounds and hormonal profiles
and where possible, confirmed by characterization of the underlying
genetic defect (Table 1). In all patients, gonads were removed as a
prophylactic measure and no cases gave rise to clinical suspicion of a
tumor. Bilateral specimens were available from 28 patients and a uni-
lateral specimen from two patients.
The gonads of eight control patients, aged 3 months to 13 yr, who
suffered from sudden infant death syndrome or sudden death after
trauma, were examined to compare staining and counting results.
Use of tissues for scientific reasons was approved by an institutional
review board (MEC 02.981). The samples were used according to the
Code for Proper Secondary Use of Human Tissue in The Netherlands,
as developed by the Dutch Federation of Medical Scientific Societies
(version 2002).
Immunohistochemical staining
After routine fixation in 10% formalin, 5-m-thick slices were pre-
pared. Poorly preserved samples were excluded from the study. The
antibodies used for immunohistochemistry and a schematic represen-
tation of the applied protocols are represented in Table 2. Slides were
incubated with the primary antibodies in an appropriate dilution. In
between the incubation steps, they were washed in a PBS-Tween 20
0.01% solution. Staining was performed using diaminobenzidine/H2O2
or New Fuchsin/Naphtol ASMX phosphate and counterstaining with
hematoxylin. As positive controls, normal adult male gonadal tissue for
VASA and seminoma for PLAP, c-KIT, testis-specific protein Y encoded
(TSPY), and OCT3/4 were used.
Double-staining. After pretreatment with H2O2 and pressure cooking,
sections were incubated with VASA (overnight) and OCT3/4 (2 h).
OCT3/4 was detected using the avidin-biotin-alkaline phosphatase
complex and Fast Blue/Naphtol ASMX phosphate for a blue staining.
After this, free biotin was blocked using a blocking KIT (Vector Labo-
ratories, Burlingame CA). VASA was detected, using the avidin biotin-
horseradish peroxidase complex with 3-amino-9-ethyl-carbazole
(Sigma, Steinheim, Germany)/H2O2, resulting in a red staining. A male
gonad containing normal tissue and CIS served as a positive control.
Quantification of results
General morphology of tissue samples was assessed by a pathologist
experienced in germ cell pathology (J.W.O.). Eventual artifacts due to the
fixation procedure were not taken into account in the final analysis.
Results were quantified as follows: for each tissue sample, 500 sem-
iniferous tubules were assessed for the staining pattern of OCT3/4,
VASA, and TSPY. One tubule was considered positive for a marker if
at least one germ cell in the tubule stained clearly positive. All counts
were performed by the same observer (M.C.), blinded for age and origin
(patient or control) of the sample. The obtained data were graphically
depicted using the SPSS statistical system (SPSS, Inc., Chicago, IL).
Determination of ploidy
Ploidy of the CIS samples was determined by fluorescent in situ
hybridization. Therefore, tissue sections of 5 m were digested with
0.0005% pepsin (Sigma-Aldrich, Zwijndrecht, The Netherlands) in 0.01
mol/liter HCl for 1 min at 37 C, rinsed in demiwater and dehydrated.
The protocol was used according to Hopman et al. (24). The following
centromeric probes were used: chromosome 1 (pUC1.77), 12 (p12h8)
(25, 26), X (BamH1), and Y (DYZ3). Probes were labeled with biotin-16-
deoxyuridine 5-triphosphate (Roche, Mannheim, Germany) using a
nick-translation kit (Life Technologies, Inc., Paisley, UK). After dena-
turation (73 C for 5 min in hybmix), they were preannealed with an
excess of Cot-1 DNA (Life Technologies) added to denatured slides (3
min in 70% formamide/2  saline sodium citrate (pH 7.0), 5 min in 70%
ethanol at 20C, and dehydrated) and hybridized for 48 h. Slides were
washed in 50% formamide/2 saline sodium citrate. The hybrids were
visualized with Cy3-conjugated avidin antibody (1:50; Jackson Immu-
noResearch, West Grove, PA).
TABLE 1. Diagnosis of patients with undervirilization syndromes, sex of rearing, and localization of the gonads at gonadectomy
Diagnosis Genetic defectidentified Sex of rearing
Localization
Age
CIS
Abdominal Inguinal Abdominal Inguinal
CAIS 13/15 Female 5 10 18 1/5 0/10
PAIS 3/5 Female 1 4 13 0/1 1/4
17-HSD deficiency 5/6 Female 0 6 4 0/0 1/6
Leydig cell hypoplasia 1/2 Female 0 2 0/0 0/2
Unknown 0/2 1 Female, 1 male 0 2 0/0 0/2
Total 22/30 29 Female, 1 male 6 24 1/6 2/24
CIS according to diagnosis, age and gonadal localization.
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Results
General morphology of gonads and germ cells
The gonads of patients exhibited an immature aspect of
tubules and cells. Dissociation between epididymis and testis
was observed in four samples. Seminiferous tubules were
small, compared with controls; branching tubules were en-
countered in four patients. The degree of peritubular and
interstitial fibrosis and thickening of the basal membrane
was variable. Apparent Leydig cell hyperplasia was found
after puberty (six samples). Sertoli cell-only nodules and
nodular hyperplasia of Sertoli cells were encountered in
older patients (eight samples).
Germ cells were found in 28 of 30 patients and 50 of 58
gonads. Theywere very large and irregular of shape, with an
abundant pale cytoplasm and a hyperchromatic nucleus.
Multinucleated spermatogonia were often encountered. No
maturation of germ cells, expected based on age, was ob-
served, except for twopubertal partial androgen insensitivity
syndrome (PAIS) patients in whom spermatocytes and sper-
matids were seen. Spermatozoawere never found. The num-
ber of germ cells was high in the youngest patients, but a
progressive loss of germ cells was notedwith advancing age.
This loss presented itself as patchy: certain areas maintained
an adequate number of germ cells, whereas in other areas all
germ cells had disappeared. Except for the PAIS patients, the
end result as could be appreciated in postpubertal patients
was a Sertoli-cell only pattern in atrophic tubules throughout
the gonad. On pure morphological grounds, an adult CIS
pattern was discovered bilaterally in one 18-yr-old CAIS
patient. In many other patients, the aberrant appearance of
the germ cells raised suspicion about the presence of CIS
because their morphology largely met the World Health
Organization (WHO) criteria (Table 3). Immunohistochem-
ical staining forOCT3/4, c-KIT, PLAP, TSPY, andVASA, and
double staining for the combination OCT3/4-VASA was
performed.
Staining results for OCT3/4, c-KIT and PLAP (Fig. 1)
OCT3/4-positive germ cells were found in all the gonads
of patients younger than 9 months of age. OCT3/4 was also
widely present in a control 3 months old, whereas at 5 and
6 months, only three and two of 500 tubules, respectively,
contained an OCT3/4-positive germ cell. Thereafter, no
OCT3/4-positive cells were identified in controls. In all but
three patients, OCT3/4 expression had disappeared at 9
months: one 4-yr-old patient with 17-hydroxysteroid de-
hydrogenase (HSD) deficiency, one 13-yr-old PAIS patient
and the CAIS patient 18 yr old in whom CIS was discovered
in the hematoxylin-eosin staining. In this patient, OCT3/4-
positive cells corresponded with the CIS cells on the hema-
toxylin-eosin staining. In the former two patients, the mor-
phology of the germ cells was judged as clearly aberrant (see
above text). The distribution of the OCT3/4-positive cells
throughout the gonad in these three patients was different
from the distribution pattern in younger patients and con-
trols: in the former, OCT3/4-positive tubules were confined
TABLE 3. WHO criteria for the diagnosis of CIS (WHO
classification of tumors, international agency for research on
cancer) (39)
Criteria
● Larger than normal spermatogonia
● Clear or vacuolated cytoplasm rich in glycogen
● Nuclei: large, irregular, hyperchromatic
● Nucleoli: one or more large, irregular
● (Abnormal) mitoses
● Basally located cells
● Spermatogenesis commonly absent
● Segmental involvement of tubules
TABLE 2. Schematic representation of origin and protocols used for the different antibodies
Origin Dilution Pretreatment HIAR Incubation Secondaryantibody AB-complex Chromogen
Primary antibody
VASA Kindly provided by Dr. D. H.
Castrillon (Department of
Pathology, NB6.452,
University of Texas,
Southwestern Medical
Center, Dallas, TX)
1/2000 No Yes Overnight, 4 C SWAR-bio ABC-AP New Fuchsine
PLAP Cell Marque (Hot Springs, AR) 1/200 No Yes Overnight, 4 C RAM-bio ABC-AP New Fuchsine
c-KIT Dako-Cytomation (Glostrup,
Denmark)
1/500 No Yes Overnight, 4 C SWAR-bio ABC-AP New Fuchsine
TSPY Kindly provided by Prof. C. Lau
(Department of Medicine, VA
Medical Center, University of
California, San Francisco,
CA)
1/3000 No No Overnight, 4 C SWAR-bio ABC-AP New Fuchsine
OCT3/4 Santa Cruz Biotechnology
(Santa Cruz, CA)
1/1000 H2O2 for
5 min
Yes 2 h, RT HAG-bio ABC-HRP DAP
Secondary antibody
SWAR Dako-Cytomation 1/200
RAM Dako-Cytomation 1/200
HAG Vector Laboratories
(Burlingame, CA)
1/200
HIAR, Heat-induced antigen retrieval (38); SWAR-bio, swine antirabbit antibody, biotin labeled; RAM-bio, rabbit antimouse antibody, biotin
labeled; HAG-bio, horse antigoat antibody, biotin labeled; AB-complex, streptavidin-biotin complex; ABC-AP, streptavidin-biotin-alkaline
phosphatase complex; ABC-HRP, streptavidin-biotin-horseradish peroxidase complex; RT, room temperature; DAP, diaminobenzidine.
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to a specific area of the gonad, separated from the unstained
areas by interstitial fibrous septa, whereas in young patients
and controls, OCT3/4-positive cells were scattered through-
out the gonad, without any preference for a certain area (Fig.
2). Also within the tubules, the distribution of OCT3/4-pos-
itive cells was different: In young patients and controls, they
were found almost exclusively centrally in the tubule, sep-
arated from the basal lamina by at least one layer of Sertoli
cells. In the 13-yr-old PAIS patient and the 18-yr-old CAIS
patient, OCT3/4-positive cells were confined to the basal
lamina, whereas in the 4-yr-old patient with 17-HSD defi-
ciency, OCT3/4-positive cells were equally present centrally
and along the basal lamina. This was nicely demonstrated in
the OCT3/4-VASA double staining (see text below).
Staining patterns for c-KIT and PLAP were comparable
with the OCT3/4 staining, for both timing of disappearance
of the marker and localization of positive cells within the
tubules, but the color intensitywas generallyweaker than the
OCT3/4 staining.
Staining results for VASA and TSPY (Figs. 3 and 4)
VASA is a general marker for germ cells (13) and thus
allowed us to estimate the total number of germ cells
throughout time in the study population relative to the con-
trols. In the latter, VASA-positive germ cells were seen in
nearly all the tubules at every age. In the study population,
the number of tubules expressing VASA was comparable
with controls only shortly after birth. From the 10th month
onward, a rapid and progressive decline in VASA expression
was observed, suggesting a massive loss of germ cells. This
loss wasmanifest in all diagnostic groups, except in the PAIS
patients, who maintained about two thirds of their germ cell
population, compared with controls at the age of 15 yr.
TSPY stains spermatogonia of adult men (27) andwas also
observed in prespermatogonia of fetal testes during the sec-
ond and third trimester of gestation (22). No data exist on the
expression of TSPY in prepubertal children. In controls, TSPY
expression clearly differed from VASA expression: whereas
VASA stained all the germ cells, irrespective of age, TSPY
expressionwas gradually up-regulated and reached the level
of VASA expression only around puberty. In patients, how-
ever, staining of adjacent slides for TSPY and VASA dem-
onstrated that, as for VASA, TSPY stained all the (remaining)
germ cells at every age. Thus, in controls, VASA was ex-
pressed at a constant level throughout time, pointing to a
continuous presence of germ cells in almost every tubular
cross-section, whereas TSPY expression increased gradually.
In patients, both TSPY and VASA were highly expressed
during the first year of life and showed a parallel decrease
thereafter. Interestingly, the intensity of the TSPY staining in
the patient population was extremely high, compared with
FIG. 1. Staining results for OCT3/4: number of tubules containing at
least one OCT3/4-positive germ cell (y-axis) according to age (x-axis).
Note the high and prolonged OCT3/4 expression in patients, com-
pared with controls, during the first year of life. No OCT3/4-positive
tubules are found anymore in the control patients above the age of 6
months and the patient population above the age of 8 months, except
for the 4-yr-old patient with 17-HSD deficiency (10 of 500 positive
tubules in one gonad), the 14-yr-old PAIS patient (133 of 500 positive
tubules in one gonad), and the 18-yr-old CAIS patient (187 of 500
positive tubules in one gonad and 22 of 500 positive tubules in the
other gonad) (arrows).
FIG. 2. A,OCT3/4-positive tubules scattered throughout the gonad in
a 6-month-old patient with 17-HSD deficiency. Note the central
position of the OCT3/4-positive cells within the tubules (OCT3/4
staining; magnification, 100). B, OCT3/4-positive tubules in a 13-
yr-old PAIS patient. The OCT3/4-positive tubules are confined to one
limited area of the gonad, separated from the OCT3/4-negative areas
by fibrous septa (OCT3/4 staining; magnification, 100).
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controls, a normal adult male testis, and a series of fetal testis
published elsewhere (22) (Fig. 5).
OCT3/4-VASA double staining (Fig. 6)
This staining was performed to appreciate the position of
OCT3/4-positive germ cells relative to the overall germ cell
population and the basal lamina within the tubule.
The 3-month-old control and the patients younger than 9
months of age showed the same staining patterns: OCT3/
4-positive cells were almost exclusively located centrally in
the tubule, whereas VASA-positive cells lined up along the
basal lamina. OCT3/4 positivity excluded VASA positivity
in the same germ cell. The 13-yr-old PAIS patient and the
18-yr-old CAIS patient showed a different distribution pat-
tern with OCT3/4-positive cells lying almost exclusively on
the basal lamina. VASA expression was lost in tubules ex-
pressing OCT3/4. The 4-yr-old patient with 17-HSD defi-
ciency showed an intermediate pattern: OCT3/4-positive
cells were found equally in the tubular center and on the
basal lamina. Some of these germ cells coexpressed VASA,
and VASA-positive-OCT3/4-negative cells were also seen
within the same tubule.
Results of ploidy determination
The precursor CIS lesions of seminomas and nonsemino-
mas are aneuploid (28, 29). To evaluate the ploidy of OCT3/
4-positive cells in the 13-yr-old PAIS patient and the 18-yr-
old CAIS patient, fluorescent in situ hybridization analysis
with centromeric probes for chromosomes 1, 12, X, andYwas
performed. In these patients, the OCT3/4-positive regions
were found to be diploid.
Discussion
We studied 58 gonadectomy and gonadal biopsy samples
in 30 patients with undervirilization syndromes to investi-
gate the relationship betweenmaturation delay and progres-
sion to CIS. To our knowledge, this represents the largest
series ever published. Despite a certain heterogeneity in clin-
ical diagnoses, we consider the group of undervirilization
FIG. 3. Staining results for VASA. Note the loss of germ cells around puberty in all the patient groups, except for the PAIS patients and the
18-yr-old CAIS patient with bilateral OCT3/4-positive cells.
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syndromes as homogenous, taking into account the normal
embryonic gonadal development and the common end result
(a defective or absent action of androgens on the end organs)
that characterizes these syndromes and opposes them to the
gonadal dysgenesis syndromes. An important variable that
we were not able to correct for is the localization of the
gonads, which was abdominal in six of 30 patients (20%) and
inguinal in 24 of 30 patients (80%). However, the finding that
two of three CIS lesions were detected in inguinal gonads
underscores the malignant potential of partially descended
testes (Table 1).
The general morphology of gonads and germ cells in our
patient series did not differ from previous findings (8, 9, 18),
but the timing and pattern of germ cell loss are described
systematically for the first time. The cryptorchid position of
the gonads in our study population certainly accounts for
this loss of germ cells, alone or in combination with other
pathogenetic mechanisms relative to the underlying disease.
OCT3/4, PLAP, and c-KIT are well-established markers
for the diagnosis of CIS and invasive germ cell tumors in
adults (14–16). They are also used to detect CIS in dysgenetic
gonads of young children (17, 18) and fetal gonads (19).
However, the expression of these markers is not limited to
malignant conditions. They have been demonstrated in the
developing fetal testes, only to disappear well beyond birth
(22), whereas TSPY and VASA are expressed throughout life
(13, 27). High and prolonged expression of c-KIT, OCT3/4,
and PLAP has been observed in dysgenetic gonads and go-
nads of patients with chromosomal anomalies and has been
related to a degree ofmaturation delay (20, 21, 30) (Cools,M.,
F. Honecker, H. Stoop, J. Veltman, R. De Krijger, E. Steyer-
berg, K. Wolffenbuttel, S. L. S. Drop, and L. H. J. Looijenga,
submitted for publication). This condition itself predisposes
germ cells to malignancy (23).
OCT3/4 is a transcription factor, normally expressed in
embryonic stem cells and embryonic germ cells, and is es-
sential in regulating pluripotency and differentiation (14).
Recently a specific role of OCT3/4 for the survival of mi-
gratory primordial germ cells has been demonstrated, pre-
venting them from premature apoptosis (31). Moreover,
OCT3/4 has been shown to be consistently present in various
germ cell tumors, including CIS and gonadoblastoma (14,
FIG. 4. Staining results for TSPY. Note the analogous pattern of germ cell loss for the different patient groups, compared with VASA, but the
increase in TSPY expression in the controls, which is different from the constant VASA expression in this group.
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32). By modulating the level of OCT3/4 expression in vitro
in mice embryonic stem cell-derived tumors, the malignant
phenotype of the tumor cells could be changed, suggesting
that OCT3/4 is of pathogenetic relevance in the development
of these tumors (33).
In our series, patients younger than 9 months of age
showed a prolonged and higher OCT3/4 expression level,
compared with controls. This is in line with previously pub-
lished data in which OCT3/4 was detected in the gonads of
a 9-month-old AIS patient but disappeared in older patients
(20). OCT3/4 expression was never seen in patients older
than 9 months, except for three cases. In the two oldest, in
contrast to younger patients and controls, OCT3/4-positive
cells were limited to one specific region of the gonad, in
which the germ cells homogenously stained positive for this
marker anddid not expressVASA.Within the tubule,OCT3/
4-positive cells stuck to the basal lamina, a pattern that is
generally found in CIS. The normal central position of
OCT3/4-positive cells in the developing tubules, because it
was encountered in young patients and controls, was de-
FIG. 5. TSPY staining (magnification, 400). Abundant TSPY ex-
pression in a 10-month-old CAIS patient (A), comparedwith a control,
18 months of age (B).
FIG. 6. A, OCT3/4 (blue)-VASA (red) double staining (200) in a
1-month-old CAIS patient. OCT3/4-positive cells are separated from
the basal lamina by at least one layer of Sertoli cells; VASA-positive
cells are mainly found on the basal lamina. B, OCT3/4 (blue)-VASA
(red) double staining (200) in a 13-yr-old PAIS patient. OCT3/4-
positive cells are found almost exclusively along the basal lamina.
Tubules expressing OCT3/4 have almost completely lost VASA ex-
pression. C, OCT3/4 (blue)-VASA (red) double staining (200) in a
4-yr-old 17-HSD deficiency patient. OCT3/4-positive cells are found
centrally in the tubule and along the basal lamina. VASA expression
is maintained in OCT3/4-positive tubules. Some germ cells coexpress
OCT3/4 and VASA.
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scribed previously, and it was suggested that by reaching the
basal lamina, early germ cells lose their pluripotency and
start to differentiate (22). An intermediate pattern was found
in one of six patients with 17-HSD deficiency, 4 yr of age:
OCT3/4-positive germ cells were confined to a specific re-
gion of the gonad, but within the tubule, they were found
both in a peripheral and a central position. Tubules with
OCT3/4-positive cells also expressed VASA, sometimes
showing coexpression of these two markers in the same cell.
The remaining five patients with 17-HSDdeficiency did not
differ from other patients in our series, suggesting that this
group does not represent a separate entity.
Thus, a possible pathogenetic mechanism for the devel-
opment of germ cell neoplasia emerges: the central OCT3/
4-positive germ cells, scattered throughout the gonad are
delayed in maturation. By moving toward the basal lamina,
they will lose their pluripotency and eventually start to dif-
ferentiate. If this process does not occur in one OCT3/4-
positive cell and the cell is not removed by an apoptotic or
other mechanism, clonal expansion of this pluripotent cell
may lead to the CIS pattern as it was encountered in the
4-yr-old patient, and at a later age to the typical CIS pattern
as it is seen in adults. The expression of PLAP and c-KIT was
similar to OCT3/4 but showed less consistency. Therefore,
we conclude that OCT3/4 is the best marker to describe
maturation delay and CIS in patients with undervirilization
syndromes. Age of the patient, distribution of OCT3/4-pos-
itive cells throughout the gonad, and staining pattern within
the tubule seem to be useful additional tools to differentiate
betweenmaturation delay and CIS in the young patient. Our
results suggest that the presence of germ cells positive for
OCT3/4, PLAP, or c-KIT in patients younger than 1 yr is in
accordance with the expected maturation delay in this pa-
tient group and is thereby insufficient for the diagnosis of
CIS. However, the relevance and applicability of these tools
in larger patient series and other diagnostic groups must be
tested before they can be widely accepted as essential diag-
nostic criteria.
An intriguing finding in our patient population and sim-
ilar to the findings of Schnieders et al. (27) was the abnormal
and abundant expression pattern of TSPY. The TSPY gene
maps to the short arm of the Y chromosome, close to the
centromeric region, in which it is highly repeated. Although
its function is not fully clarified, it is thought to regulate the
mitotic proliferation of spermatogonia (27). The expression
of TSPY in dysgenetic gonads has been related to the devel-
opment of gonadoblastoma (32, 34). It is tempting to spec-
ulate that TSPY expression is up-regulated in germ cells
residing in an unfavorable environment in an attempt to
survive and proliferate. The combination of maturation de-
lay, prolonged expression of OCT3/4, and abundant TSPY
expression can provide the surviving germ cell with an im-
portant proliferative advantage, rapidly leading to clonal
expansion and the development of CIS.
The CIS cells in the 18-yr-old CAIS patient and the 13-yr-
old PAIS patient were diploid. However, polyploidization is
known to be an early event in the development of CIS in the
adult testis (28, 29, 35). On the other hand, gonadoblastomas
arising in dysgenetic gonads are often found to be diploid
(28, 36), although aneuploidy was also described (37). It is
unclear so far whether polyploidization did not take place
yet in our patients, thereby representing a very early CIS
stage, or alternatively, whether polyploidization is not es-
sential in the development of CIS in the gonads of under-
virilized patients.
In conclusion, we discovered CIS lesions in three of 30
patients (10%) and four of 58 gonadectomy or biopsy spec-
imens (6.9%). Morphological criteria for the detection of CIS
in adult patients and the classic use of immunohistochemical
markers were insufficient to describe CIS in our patients.
Based on our results, patient age, distribution pattern of
OCT3/4-positive cells throughout the gonad, and their po-
sition within the seminiferous tubule can additionally be
used to distinguish maturation delay from CIS in young
patients with undervirilization syndromes. However, larger
patient series and extension of these tools to other situations
that are characterized by gonadal maturation delay and in-
creased risk for germ cell neoplasia are essential before they
can be accepted as essential criteria for the diagnosis of CIS
in young patients.
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